STAASTAAR Surgical Company

1. Oct 5, 2026On September 8, 2026, STAAR Surgical Company (the “Company”) announced that it appointed David Bailey as Chief Commercial Officer, effective that day Since 2010, Mr. Bailey has been the Founder and President of DB Consulting, a Switzerland-based strategic advisory firm providing advice to private equity firms and …Director or officer change · Form 8-K/A
2. Sep 10, 2026On September 8, 2026, STAAR Surgical Company (the “Company”) announced that it appointed David Bailey as Chief Commercial Officer, effective that day Since 2010, Mr. Bailey has been the Founder and President of DB Consulting, a Switzerland-based strategic advisory firm providing advice to private equity firms and …Director or officer change · Form 8-K
3. Aug 12, 2026STAAR Surgical Reports Second Quarter 2026 Results.Earnings release · press release
4. Aug 6, 2026On August 4, 2026, STAAR Surgical Company (the “Company” or “STAAR”) announced that the Company’s Board of Directors (the “Board”) appointed Warren Foust as President and Chief Executive Officer (“CEO”) and new member of the Board, effective August 4, 2026 (the “Effective Date”)Director or officer change · Form 8-K
5. Jun 22, 2026On June 18, 2026, STAAR Surgical Company (the “Company”) held its 2026 Annual Meeting of Shareholders (the “2026 Annual Meeting”)Director or officer change · Form 8-K
6. Jun 9, 2026On June 8, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of STAAR Surgical Company (the “Company”) approved an increase to the annual base salary of Deborah Andrews, the Company's Interim Co-Chief Executive Officer and Chief Financial Officer from $512,000 to $575,000.Director or officer change · Form 8-K
7. May 13, 2026STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter.Earnings release · press release
8. Apr 8, 2026STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026.Regulation FD disclosure · press release
9. Mar 3, 2026STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results.Earnings release · press release
10. Feb 5, 2026On February 4, 2026, STAAR Surgical Company (the “Company”) entered into a letter agreement with Nathaniel Sisitsky, the Company’s Chief Legal Officer and Corporate Secretary (the “Letter Agreement”), that provides for Mr. Sisitsky’s termination of employment, effective as of February 4, 2026 (the “Separation Date”)Director or officer change · Form 8-K
11. Feb 2, 2026On February 1, 2026, the Board of Directors (the “Board”) of STAAR Surgical Company (the “Company”) appointed Warren Foust and Deborah Andrews as Interim Co-Chief Executive Officers, effective February 1, 2026 (the “Effective Date”)Director or officer change · Form 8-K
12. Jan 16, 2026On January 15, 2026, the Board of Directors (the “Board”) of STAAR Surgical Company (the “Company”) elected a new Board Chair, approved changes to the composition and leadership of the Board’s three standing committees, and established two new Board committees.Director or officer change · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.